| Product No. | Product Name | Size |
| Prices effective: 01-Feb-06 | | |
| ALX-101-003-G001 | beta-Alanine | 1 g |
| ALX-101-004-G025 | L-Arginine | 25 g |
| ALX-101-005-G005 | D-Arginine | 5 g |
| ALX-101-010-G001 | L-Aspartic acid | 1 g |
| ALX-101-011-G001 | D-Aspartic acid | 1 g |
| ALX-101-012-G010 | L-Cysteine . hydrochloride | 10 g |
| ALX-101-016-G005 | L-Glutamine | 5 g |
| ALX-101-017-G001 | D-Glutamine | 1 g |
| ALX-101-018-G001 | L-Glutamic acid | 1 g |
| ALX-101-019-G001 | D-Glutamic acid | 1 g |
| ALX-101-036-G005 | L-Ornithine . hydrochloride | 5 g |
| ALX-101-036-G025 | L-Ornithine . hydrochloride | 25 g |
| ALX-101-037-G001 | D-Ornithine . hydrochloride | 1 g |
| ALX-101-037-G005 | D-Ornithine . hydrochloride | 5 g |
| ALX-101-051-G001 | L-Tryptophan | 1 g |
| ALX-101-057-G010 | L-Histidine . hydrochloride . monohydrate | 10 g |
| ALX-101-058-G001 | D-Histidine . hydrochloride . monohydrate | 1 g |
| ALX-104-001-G005 | Fmoc-Ala-OH | 5 g |
| ALX-104-001-G025 | Fmoc-Ala-OH | 25 g |
| ALX-104-001-G100 | Fmoc-Ala-OH | 100 g |
| ALX-104-002-G005 | Fmoc-D-Ala-OH | 5 g |
| ALX-104-002-G025 | Fmoc-D-Ala-OH | 25 g |
| ALX-104-004-G005 | Fmoc-Arg(Mtr)-OH . IPE | 5 g |
| ALX-104-004-G025 | Fmoc-Arg(Mtr)-OH . IPE | 25 g |
| ALX-104-006-G005 | Fmoc-Arg(Pmc)-OH | 5 g |
| ALX-104-006-G025 | Fmoc-Arg(Pmc)-OH | 25 g |
| ALX-104-008-G005 | Fmoc-Asn-OH | 5 g |
| ALX-104-008-G025 | Fmoc-Asn-OH | 25 g |
| ALX-104-008-G100 | Fmoc-Asn-OH | 100 g |
| ALX-104-010-G005 | Fmoc-Asn(Trt)-OH | 5 g |
| ALX-104-010-G025 | Fmoc-Asn(Trt)-OH | 25 g |
| ALX-104-010-G100 | Fmoc-Asn(Trt)-OH | 100 g |
| ALX-104-012-G001 | Fmoc-Asp-OtBu | 1 g |
| ALX-104-012-G005 | Fmoc-Asp-OtBu | 5 g |
| ALX-104-012-G025 | Fmoc-Asp-OtBu | 25 g |
| ALX-104-013-G005 | Fmoc-Asp(OBzl)-OH | 5 g |
| ALX-104-013-G025 | Fmoc-Asp(OBzl)-OH | 25 g |
| ALX-104-014-G005 | Fmoc-Asp(OtBu)-OH | 5 g |
| ALX-104-014-G025 | Fmoc-Asp(OtBu)-OH | 25 g |
| ALX-104-014-G100 | Fmoc-Asp(OtBu)-OH | 100 g |
| ALX-104-015-G001 | Fmoc-D-Asp(OtBu)-OH | 1 g |
| ALX-104-015-G005 | Fmoc-D-Asp(OtBu)-OH | 5 g |
| ALX-104-015-G025 | Fmoc-D-Asp(OtBu)-OH | 25 g |
| ALX-104-016-G005 | Fmoc-Cys(Acm)-OH | 5 g |
| ALX-104-016-G025 | Fmoc-Cys(Acm)-OH | 25 g |
| ALX-104-016-G100 | Fmoc-Cys(Acm)-OH | 100 g |
| ALX-104-018-G005 | Fmoc-Cys(tBu)-OH | 5 g |
| ALX-104-018-G025 | Fmoc-Cys(tBu)-OH | 25 g |
| ALX-104-018-G100 | Fmoc-Cys(tBu)-OH | 100 g |
| ALX-104-021-G005 | Fmoc-Cys(Trt)-OH | 5 g |
| ALX-104-021-G025 | Fmoc-Cys(Trt)-OH | 25 g |
| ALX-104-021-G100 | Fmoc-Cys(Trt)-OH | 100 g |
| ALX-104-022-G005 | Fmoc-Gln-OH | 5 g |
| ALX-104-022-G025 | Fmoc-Gln-OH | 25 g |
| ALX-104-022-G100 | Fmoc-Gln-OH | 100 g |
| ALX-104-024-G005 | Fmoc-Gln(Trt)-OH | 5 g |
| ALX-104-024-G025 | Fmoc-Gln(Trt)-OH | 25 g |
| ALX-104-024-G100 | Fmoc-Gln(Trt)-OH | 100 g |
| ALX-104-026-G001 | Fmoc-Glu-OtBu | 1 g |
| ALX-104-026-G005 | Fmoc-Glu-OtBu | 5 g |
| ALX-104-026-G025 | Fmoc-Glu-OtBu | 25 g |
| ALX-104-027-G005 | Fmoc-Glu(OBzl)-OH | 5 g |
| ALX-104-027-G025 | Fmoc-Glu(OBzl)-OH | 25 g |
| ALX-104-028-G005 | Fmoc-Glu(OtBu)-OH | 5 g |
| ALX-104-028-G025 | Fmoc-Glu(OtBu)-OH | 25 g |
| ALX-104-028-G100 | Fmoc-Glu(OtBu)-OH | 100 g |
| ALX-104-029-G001 | Fmoc-D-Glu(OtBu)-OH | 1 g |
| ALX-104-029-G005 | Fmoc-D-Glu(OtBu)-OH | 5 g |
| ALX-104-029-G025 | Fmoc-D-Glu(OtBu)-OH | 25 g |
| ALX-104-030-G005 | Fmoc-Gly-OH | 5 g |
| ALX-104-030-G025 | Fmoc-Gly-OH | 25 g |
| ALX-104-030-G100 | Fmoc-Gly-OH | 100 g |
| ALX-104-033-G005 | Fmoc-His(Trt)-OH | 5 g |
| ALX-104-033-G025 | Fmoc-His(Trt)-OH | 25 g |
| ALX-104-033-G100 | Fmoc-His(Trt)-OH | 100 g |
| ALX-104-034-G005 | Fmoc-D-His(Trt)-OH | 5 g |
| ALX-104-034-G025 | Fmoc-D-His(Trt)-OH | 25 g |
| ALX-104-036-G005 | Fmoc-Ile-OH | 5 g |
| ALX-104-036-G025 | Fmoc-Ile-OH | 25 g |
| ALX-104-036-G100 | Fmoc-Ile-OH | 100 g |
| ALX-104-037-G005 | Fmoc-Leu-OH | 5 g |
| ALX-104-037-G025 | Fmoc-Leu-OH | 25 g |
| ALX-104-037-G100 | Fmoc-Leu-OH | 100 g |
| ALX-104-038-G005 | Fmoc-D-Leu-OH | 5 g |
| ALX-104-038-G025 | Fmoc-D-Leu-OH | 25 g |
| ALX-104-040-G005 | Fmoc-Lys(Boc)-OH | 5 g |
| ALX-104-040-G025 | Fmoc-Lys(Boc)-OH | 25 g |
| ALX-104-040-G100 | Fmoc-Lys(Boc)-OH | 100 g |
| ALX-104-041-G001 | Fmoc-D-Lys(Boc)-OH | 1 g |
| ALX-104-041-G005 | Fmoc-D-Lys(Boc)-OH | 5 g |
| ALX-104-041-G025 | Fmoc-D-Lys(Boc)-OH | 25 g |
| ALX-104-043-G005 | Fmoc-Lys(Fmoc)-OH | 5 g |
| ALX-104-043-G025 | Fmoc-Lys(Fmoc)-OH | 25 g |
| ALX-104-044-G005 | Fmoc-Met-OH | 5 g |
| ALX-104-044-G025 | Fmoc-Met-OH | 25 g |
| ALX-104-044-G100 | Fmoc-Met-OH | 100 g |
| ALX-104-045-G005 | Fmoc-D-Met-OH | 5 g |
| ALX-104-045-G025 | Fmoc-D-Met-OH | 25 g |
| ALX-104-048-G005 | Fmoc-Nle-OH | 5 g |
| ALX-104-048-G025 | Fmoc-Nle-OH | 25 g |
| ALX-104-052-G005 | Fmoc-Orn(Boc)-OH | 5 g |
| ALX-104-052-G025 | Fmoc-Orn(Boc)-OH | 25 g |
| ALX-104-053-G005 | Fmoc-Phe-OH | 5 g |
| ALX-104-053-G025 | Fmoc-Phe-OH | 25 g |
| ALX-104-053-G100 | Fmoc-Phe-OH | 100 g |
| ALX-104-054-G005 | Fmoc-D-Phe-OH | 5 g |
| ALX-104-054-G025 | Fmoc-D-Phe-OH | 25 g |
| ALX-104-059-G005 | Fmoc-Pro-OH . H2O | 5 g |
| ALX-104-059-G025 | Fmoc-Pro-OH . H2O | 25 g |
| ALX-104-059-G100 | Fmoc-Pro-OH . H2O | 100 g |
| ALX-104-060-G005 | Fmoc-D-Pro-OH | 5 g |
| ALX-104-060-G025 | Fmoc-D-Pro-OH | 25 g |
| ALX-104-065-G005 | Fmoc-Ser(tBu)-OH | 5 g |
| ALX-104-065-G025 | Fmoc-Ser(tBu)-OH | 25 g |
| ALX-104-065-G100 | Fmoc-Ser(tBu)-OH | 100 g |
| ALX-104-066-G001 | Fmoc-D-Ser(tBu)-OH | 1 g |
| ALX-104-066-G005 | Fmoc-D-Ser(tBu)-OH | 5 g |
| ALX-104-066-G025 | Fmoc-D-Ser(tBu)-OH | 25 g |
| ALX-104-067-G005 | Fmoc-Ser(Trt)-OH | 5 g |
| ALX-104-067-G025 | Fmoc-Ser(Trt)-OH | 25 g |
| ALX-104-067-G100 | Fmoc-Ser(Trt)-OH | 100 g |
| ALX-104-071-G005 | Fmoc-Thr(tBu)-OH | 5 g |
| ALX-104-071-G025 | Fmoc-Thr(tBu)-OH | 25 g |
| ALX-104-071-G100 | Fmoc-Thr(tBu)-OH | 100 g |
| ALX-104-072-G001 | Fmoc-D-Thr(tBu)-OH | 1 g |
| ALX-104-072-G005 | Fmoc-D-Thr(tBu)-OH | 5 g |
| ALX-104-072-G025 | Fmoc-D-Thr(tBu)-OH | 25 g |
| ALX-104-073-G005 | Fmoc-Trp-OH | 5 g |
| ALX-104-073-G025 | Fmoc-Trp-OH | 25 g |
| ALX-104-073-G100 | Fmoc-Trp-OH | 100 g |
| ALX-104-074-G005 | Fmoc-D-Trp-OH | 5 g |
| ALX-104-074-G025 | Fmoc-D-Trp-OH | 25 g |
| ALX-104-075-G005 | Fmoc-Trp(Boc)-OH | 5 g |
| ALX-104-075-G025 | Fmoc-Trp(Boc)-OH | 25 g |
| ALX-104-075-G100 | Fmoc-Trp(Boc)-OH | 100 g |
| ALX-104-078-G005 | Fmoc-Tyr(tBu)-OH | 5 g |
| ALX-104-078-G025 | Fmoc-Tyr(tBu)-OH | 25 g |
| ALX-104-078-G100 | Fmoc-Tyr(tBu)-OH | 100 g |
| ALX-104-081-G005 | Fmoc-Val-OH | 5 g |
| ALX-104-081-G025 | Fmoc-Val-OH | 25 g |
| ALX-104-081-G100 | Fmoc-Val-OH | 100 g |
| ALX-104-083-G005 | Fmoc-D-Val-OH | 5 g |
| ALX-104-083-G025 | Fmoc-D-Val-OH | 25 g |
| ALX-104-086-G001 | Fmoc-D-Cys(Trt)-OH | 1 g |
| ALX-104-086-G005 | Fmoc-D-Cys(Trt)-OH | 5 g |
| ALX-104-092-G005 | Fmoc-Thr(Trt)-OH | 5 g |
| ALX-104-092-G025 | Fmoc-Thr(Trt)-OH | 25 g |
| ALX-104-111-G005 | Fmoc-Arg(Pbf)-OH | 5 g |
| ALX-104-111-G025 | Fmoc-Arg(Pbf)-OH | 25 g |
| ALX-104-111-G100 | Fmoc-Arg(Pbf)-OH | 100 g |
| ALX-104-113-G001 | Fmoc-D-Arg(Pbf)-OH | 1 g |
| ALX-104-113-G005 | Fmoc-D-Arg(Pbf)-OH | 5 g |
| ALX-104-113-G025 | Fmoc-D-Arg(Pbf)-OH | 25 g |
| ALX-105-001-G005 | NG-Nitro-L-arginine | 5 g |
| ALX-105-001-G025 | NG-Nitro-L-arginine | 25 g |
| ALX-105-002-G001 | NG-Nitro-D-arginine | 1 g |
| ALX-105-002-M250 | NG-Nitro-D-arginine | 250 mg |
| ALX-105-003-G005 | L-NAME . hydrochloride | 5 g |
| ALX-105-003-G025 | L-NAME . hydrochloride | 25 g |
| ALX-105-004-G001 | D-NAME . hydrochloride | 1 g |
| ALX-105-004-G005 | D-NAME . hydrochloride | 5 g |
| ALX-105-004-M250 | D-NAME . hydrochloride | 250 mg |
| ALX-105-005-G001 | N-Acetyl-L-cysteine | 1 g |
| ALX-105-005-G005 | N-Acetyl-L-cysteine | 5 g |
| ALX-105-009-M010 | N-Methyl-D-aspartic acid | 10 mg |
| ALX-105-009-M050 | N-Methyl-D-aspartic acid | 50 mg |
| ALX-105-009-M250 | N-Methyl-D-aspartic acid | 250 mg |
| ALX-105-010-M050 | N-Methyl-L-aspartic acid | 50 mg |
| ALX-105-010-M250 | N-Methyl-L-aspartic acid | 250 mg |
| ALX-106-001-G001 | L-NMMA . monoacetate | 1 g |
| ALX-106-001-M005 | L-NMMA . monoacetate | 5 mg |
| ALX-106-001-M025 | L-NMMA . monoacetate | 25 mg |
| ALX-106-001-M100 | L-NMMA . monoacetate | 100 mg |
| ALX-106-002-M005 | D-NMMA . monoacetate | 5 mg |
| ALX-106-002-M025 | D-NMMA . monoacetate | 25 mg |
| ALX-106-002-M100 | D-NMMA . monoacetate | 100 mg |
| ALX-106-003-G005 | L-Citrulline | 5 g |
| ALX-106-004-M005 | NG-Hydroxy-L-arginine . monoacetate | 5 mg |
| ALX-106-004-M025 | NG-Hydroxy-L-arginine . monoacetate | 25 mg |
| ALX-106-005-M005 | NG, NG-Dimethyl-L-arginine . di(p-hydroxyazobenzene-p'-sulfonate) | 5 mg |
| ALX-106-005-M025 | NG, NG-Dimethyl-L-arginine . di(p-hydroxyazobenzene-p'-sulfonate) | 25 mg |
| ALX-106-006-M005 | NG, NG-Dimethyl-L-arginine . dihydrochloride | 5 mg |
| ALX-106-006-M025 | NG, NG-Dimethyl-L-arginine . dihydrochloride | 25 mg |
| ALX-106-007-M005 | NG, N'G-Dimethyl-L-arginine . di(p-hydroxyazobenzene-p'-sulfonate) | 5 mg |
| ALX-106-007-M025 | NG, N'G-Dimethyl-L-arginine . di(p-hydroxyazobenzene-p'-sulfonate) | 25 mg |
| ALX-106-008-M005 | NG, N'G-Dimethyl-L-arginine . dihydrochloride | 5 mg |
| ALX-106-008-M025 | NG, N'G-Dimethyl-L-arginine . dihydrochloride | 25 mg |
| ALX-106-010-M005 | NG-Monoethyl-L-arginine . monoacetate | 5 mg |
| ALX-106-010-M025 | NG-Monoethyl-L-arginine . monoacetate | 25 mg |
| ALX-106-011-M005 | NG-Monomethyl-L-homoarginine . monoacetate | 5 mg |
| ALX-106-011-M025 | NG-Monomethyl-L-homoarginine . monoacetate | 25 mg |
| ALX-106-012-M010 | S-Methyl-L-thiocitrulline . dihydrochloride | 10 mg |
| ALX-106-012-M050 | S-Methyl-L-thiocitrulline . dihydrochloride | 50 mg |
| ALX-106-013-M010 | L-Thiocitrulline . dihydrochloride | 10 mg |
| ALX-106-013-M050 | L-Thiocitrulline . dihydrochloride | 50 mg |
| ALX-106-014-M005 | NG-Amino-L-arginine . hydrochloride | 5 mg |
| ALX-106-015-G001 | L-allo-Isoleucine | 1 g |
| ALX-106-016-G001 | D-allo-Isoleucine | 1 g |
| ALX-106-017-M050 | L-Pipecolic acid . hydrochloride | 50 mg |
| ALX-106-020-G001 | 3-Nitro-L-tyrosine | 1 g |
| ALX-106-020-G005 | 3-Nitro-L-tyrosine | 5 g |
| ALX-106-023-M500 | 5-Hydroxy-L-tryptophan | 500 mg |
| ALX-106-024-G001 | O-Phospho-L-serine | 1 g |
| ALX-106-025-G010 | gamma-Aminobutyric acid | 10 g |
| ALX-106-026-M050 | L-alpha-Aminoadipic acid | 50 mg |
| ALX-106-026-M250 | L-alpha-Aminoadipic acid | 250 mg |
| ALX-106-027-M050 | D-alpha-Aminoadipic acid | 50 mg |
| ALX-106-027-M250 | D-alpha-Aminoadipic acid | 250 mg |
| ALX-106-028-M050 | D-Cycloserine | 50 mg |
| ALX-106-028-M250 | D-Cycloserine | 250 mg |
| ALX-106-030-G001 | p-Chloro-DL-phenylalanine | 1 g |
| ALX-106-031-M050 | p-Chloro-L-phenylalanine | 50 mg |
| ALX-106-031-M250 | p-Chloro-L-phenylalanine | 250 mg |
| ALX-106-035-G001 | 4-Hydroxy-D-phenylglycine | 1 g |
| ALX-106-037-M025 | L-Cycloserine | 25 mg |
| ALX-106-037-M100 | L-Cycloserine | 100 mg |
| ALX-120-002-G005 | 2-Chlorotritylchloride resin | 5 g |
| ALX-120-002-G025 | 2-Chlorotritylchloride resin | 25 g |
| ALX-120-002-G100 | 2-Chlorotritylchloride resin | 100 g |
| ALX-121-002-G100 | TBTU | 100 g |
| ALX-121-002-G250 | TBTU | 250 g |
| ALX-121-002-G500 | TBTU | 500 g |
| ALX-121-003-G100 | HBTU | 100 g |
| ALX-121-003-G250 | HBTU | 250 g |
| ALX-121-003-G500 | HBTU | 500 g |
| ALX-123-001-G005 | Fmoc-Amide-Linker | 5 g |
| ALX-123-010-G001 | beta-(S-p-Methoxybenzyl)-beta,beta-cyclopentamethylene-propionic acid | 1 g |
| ALX-123-010-G005 | beta-(S-p-Methoxybenzyl)-beta,beta-cyclopentamethylene-propionic acid | 5 g |
| ALX-151-001-PC01 | beta-Amyloid (1-43) | 0.1 mg* |
| ALX-151-001-PC05 | beta-Amyloid (1-43) | 0.5 mg* |
| ALX-151-002-P001 | beta-Amyloid (1-42) | 1 mg* |
| ALX-151-002-PC05 | beta-Amyloid (1-42) | 0.5 mg* |
| ALX-151-003-P001 | beta-Amyloid (1-40) | 1 mg* |
| ALX-151-003-PC05 | beta-Amyloid (1-40) | 0.5 mg* |
| ALX-151-005-P001 | beta-Amyloid (1-28) | 1 mg* |
| ALX-151-005-PC05 | beta-Amyloid (1-28) | 0.5 mg* |
| ALX-151-007-P001 | [Gln11]-beta-Amyloid (1-16) | 1 mg* |
| ALX-151-007-PC05 | [Gln11]-beta-Amyloid (1-16) | 0.5 mg* |
| ALX-151-008-P001 | beta-Amyloid (25-35) | 1 mg* |
| ALX-151-008-P005 | beta-Amyloid (25-35) | 5 mg* |
| ALX-151-009-P001 | beta-Amyloid (10-20) | 1 mg* |
| ALX-151-009-P005 | beta-Amyloid (10-20) | 5 mg* |
| ALX-151-011-P001 | beta-Amyloid / A4 Protein Precursor [APP] (328-332) | 1 mg* |
| ALX-151-011-P005 | beta-Amyloid / A4 Protein Precursor [APP] (328-332) | 5 mg* |
| ALX-151-013-MC05 | Apamin | 0.5 mg |
| ALX-151-014-M001 | cAMP-dependent Protein Kinase Inhibitor (5-24) | 1 mg |
| ALX-151-014-MC05 | cAMP-dependent Protein Kinase Inhibitor (5-24) | 0.5 mg |
| ALX-151-016-M001 | cAMP-dependent Protein Kinase Inhibitor (5-22) amide | 1 mg |
| ALX-151-016-MC05 | cAMP-dependent Protein Kinase Inhibitor (5-22) amide | 0.5 mg |
| ALX-151-017-M001 | cAMP-dependent Protein Kinase Inhibitor (14-24) amide | 1 mg |
| ALX-151-017-M005 | cAMP-dependent Protein Kinase Inhibitor (14-24) amide | 5 mg |
| ALX-151-018-M001 | cAMP-dependent Protein Kinase Inhibitor (5-24) amide | 1 mg |
| ALX-151-018-MC05 | cAMP-dependent Protein Kinase Inhibitor (5-24) amide | 0.5 mg |
| ALX-151-019-M001 | cAMP-dependent Protein Kinase Substrate | 1 mg |
| ALX-151-019-MC05 | cAMP-dependent Protein Kinase Substrate | 0.5 mg |
| ALX-151-020-M010 | N-Acetyl-Asp-Glu-OH | 10 mg |
| ALX-151-020-M050 | N-Acetyl-Asp-Glu-OH | 50 mg |
| ALX-151-021-M001 | H-Arg-Gly-Tyr-Ser-Leu-Gly-OH | 1 mg |
| ALX-151-021-M005 | H-Arg-Gly-Tyr-Ser-Leu-Gly-OH | 5 mg |
| ALX-151-022-M001 | H-Arg-Gly-Tyr-Ala-Leu-Gly-OH | 1 mg |
| ALX-151-022-M005 | H-Arg-Gly-Tyr-Ala-Leu-Gly-OH | 5 mg |
| ALX-151-023-M001 | Autocamtide-2 | 1 mg |
| ALX-151-023-M005 | Autocamtide-2 | 5 mg |
| ALX-151-024-M001 | H-Ala-Pro-Arg-Thr-Pro-Gly-Gly-Arg-Arg-OH | 1 mg |
| ALX-151-024-M005 | H-Ala-Pro-Arg-Thr-Pro-Gly-Gly-Arg-Arg-OH | 5 mg |
| ALX-151-026-M001 | N-Acetyl-Asp-Tyr(2-malonyl)-Val-Pro-Met-Leu-NH2 | 1 mg |
| ALX-151-027-M001 | N-Acetyl-Asp-Tyr(PO3H2)-Val-Pro-Met-Leu-NH2 | 1 mg |
| ALX-151-028-M001 | Protein Tyrosine Kinase pp60c-src Substrate | 1 mg |
| ALX-151-028-M005 | Protein Tyrosine Kinase pp60c-src Substrate | 5 mg |
| ALX-151-029-M001 | Autocamtide-2-Related Inhibitory Peptide | 1 mg |
| ALX-151-029-M005 | Autocamtide-2-Related Inhibitory Peptide | 5 mg |
| ALX-151-030-MC05 | Autocamtide-2-Related Inhibitory Peptide (Myristoylated) | 0.5 mg |
| ALX-151-031-M001 | Caspase-3 Control Peptide | 1 mg |
| ALX-151-031-M005 | Caspase-3 Control Peptide | 5 mg |
| ALX-151-033-C050 | Blocking Peptide for PAb to Androgen Receptor (Prod. No. ALX-210-152) | 50.micro.g |
| ALX-151-034-C050 | Blocking Peptide for PAb to AIB1 (Prod. No. ALX-210-255) | 50.micro.g |
| ALX-151-035-M001 | Ac-muramyl-Ala-D-Glu-amide | 1 mg |
| ALX-151-035-M005 | Ac-muramyl-Ala-D-Glu-amide | 5 mg |
| ALX-151-036-M001 | Ac-muramyl-D-Ala-D-Glu-amide | 1 mg |
| ALX-151-036-M005 | Ac-muramyl-D-Ala-D-Glu-amide | 5 mg |
| ALX-152-001-P001 | Big Endothelin-1 (1-38) (human) | 1 mg* |
| ALX-152-001-PC01 | Big Endothelin-1 (1-38) (human) | 0.1 mg* |
| ALX-152-001-PC05 | Big Endothelin-1 (1-38) (human) | 0.5 mg* |
| ALX-152-002-PC01 | Big Endothelin-1 (1-39) (pig) | 0.1 mg* |
| ALX-152-002-PC05 | Big Endothelin-1 (1-39) (pig) | 0.5 mg* |
| ALX-152-003-PC01 | Big Endothelin-1 (1-39) (rat) | 0.1 mg* |
| ALX-152-003-PC05 | Big Endothelin-1 (1-39) (rat) | 0.5 mg* |
| ALX-152-004-PC01 | Big Endothelin-2 (1-37) (human) | 0.1 mg* |
| ALX-152-004-PC05 | Big Endothelin-2 (1-37) (human) | 0.5 mg* |
| ALX-152-006-M005 | Bradykinin | 5 mg |
| ALX-152-006-M025 | Bradykinin | 25 mg |
| ALX-152-007-PC01 | Big Endothelin-1 (1-39) (bovine) | 0.1 mg* |
| ALX-152-007-PC05 | Big Endothelin-1 (1-39) (bovine) | 0.5 mg* |
| ALX-152-012-M001 | Big Endothelin-1 (22-38) (human) | 1 mg |
| ALX-152-012-MC05 | Big Endothelin-1 (22-38) (human) | 0.5 mg |
| ALX-152-014-M001 | Big Endothelin-1 (19-37) (human), [Phe22]- | 1 mg |
| ALX-152-014-MC05 | Big Endothelin-1 (19-37) (human), [Phe22]- | 0.5 mg |
| ALX-152-018-P001 | Bombesin | 1 mg* |
| ALX-152-018-P005 | Bombesin | 5 mg* |
| ALX-152-022-M001 | BPDEtide | 1 mg |
| ALX-152-022-M005 | BPDEtide | 5 mg |
| ALX-152-023-C050 | Blocking Peptide for PAb to Ah Receptor Nuclear Translocator 3 (Prod. No. ALX-210-245) | 50.micro.g |
| ALX-152-027-1 | BimL (147-164) (human) (cell-permeable) | 1 Vial |
| ALX-152-028-1 | Bax (58-75) (human) (cell-permeable) | 1 Vial |
| ALX-152-029-1 | Bok (66-83) (human) (cell-permeable) | 1 Vial |
| ALX-153-001-M001 | Calcitonin (salmon) | 1 mg |
| ALX-153-001-MC05 | Calcitonin (salmon) | 0.5 mg |
| ALX-153-003-M001 | Casein Kinase II Substrate | 1 mg |
| ALX-153-003-M005 | Casein Kinase II Substrate | 5 mg |
| ALX-153-006-M001 | Ca2+ / Calmodulin-dependent Protein Kinase II (290-309) | 1 mg |
| ALX-153-006-MC01 | Ca2+ / Calmodulin-dependent Protein Kinase II (290-309) | 0.1 mg |
| ALX-153-008-M001 | Ca2+ / Calmodulin-dependent Protein Kinase IV Substrate | 1 mg |
| ALX-153-008-M005 | Ca2+ / Calmodulin-dependent Protein Kinase IV Substrate | 5 mg |
| ALX-153-009-M001 | Ca2+ / Calmodulin-dependent Protein Kinase II (281-289) | 1 mg |
| ALX-153-009-M005 | Ca2+ / Calmodulin-dependent Protein Kinase II (281-289) | 5 mg |
| ALX-153-010-M001 | [Ala286]-Ca2+ / Calmodulin-dependent Protein Kinase II (281-302) | 1 mg |
| ALX-153-010-MC01 | [Ala286]-Ca2+ / Calmodulin-dependent Protein Kinase II (281-302) | 0.1 mg |
| ALX-153-012-M001 | Cyclin-dependent Kinase 2 Inhibitor | 1 mg |
| ALX-153-012-M005 | Cyclin-dependent Kinase 2 Inhibitor | 5 mg |
| ALX-153-016-C050 | Blocking Peptide for Antiserum to Calreticulin (CT) (Prod. No. ALX-210-171) | 50.micro.g |
| ALX-153-017-C050 | Blocking Peptide for Antiserum to Calreticulin (NT) (Prod. No. ALX-210-170) | 50.micro.g |
| ALX-153-018-M005 | [Ala288]-Ca2+ / Calmodulin-dependent Protein Kinase II (281-289) | 5 mg |
| ALX-153-019-C100 | Blocking Peptide for PAb to CCR1 (human) (Prod. No. ALX-210-741) | 100.micro.g |
| ALX-153-020-C100 | Blocking Peptide for PAb to CCR4 (mouse) (Prod. No. ALX-210-742) | 100.micro.g |
| ALX-153-021-M001 | Calcitonin (human) | 1 mg |
| ALX-153-021-MC05 | Calcitonin (human) | 0.5 mg |
| ALX-153-023-C050 | Blocking Peptide for PAb to CREB Binding Protein (human) (Prod. No. ALX-210-229) | 50.micro.g |
| ALX-153-024-C100 | Blocking Peptide for PAb to CCR8 (human) (Prod. No. ALX-210-762) | 100.micro.g |
| ALX-153-025-C100 | Blocking Peptide for PAb to CCR8 (human) (Prod. No. ALX-210-764) | 100.micro.g |
| ALX-153-028-C050 | Blocking Peptide for PAb to Cyclophilin B (Prod. No. ALX-210-237) | 50.micro.g |
| ALX-153-029-C050 | Blocking Peptide for PAb to Caveolin-2 (rat) (Prod. No. ALX-210-240) | 50.micro.g |
| ALX-153-030-C050 | Blocking Peptide for PAb to Caveolin-3 (rat) (Prod. No. ALX-210-241) | 50.micro.g |
| ALX-153-031-C050 | Blocking Peptide for PAb to CLOCK (NT) (Prod. No. ALX-210-243) | 50.micro.g |
| ALX-153-032-C050 | Blocking Peptide for PAb to CLOCK (mouse) (CT) (Prod. No. ALX-210-244) | 50.micro.g |
| ALX-153-033-C050 | Blocking Peptide for PAb to Cyclophilin D (Prod. No. ALX-210-789) | 50.micro.g |
| ALX-153-034-C100 | Blocking Peptide for PAb to CXCR4 (mouse) (Prod. No. ALX-210-819) | 100.micro.g |
| ALX-153-035-C100 | Blocking Peptide for PAb to CXCR4 (human) (Prod. No. ALX-210-820) | 100.micro.g |
| ALX-153-036-C100 | Blocking Peptide for PAb to CCR2 (human) (Prod. No. ALX-210-821) | 100.micro.g |
| ALX-153-037-C100 | Blocking Peptide for PAb to CCR3 (human) (Prod. No. ALX-210-822) | 100.micro.g |
| ALX-153-039-C100 | Blocking Peptide for PAb to CCR5 (human) (Prod. No. ALX-210-823) | 100.micro.g |
| ALX-153-041-C500 | Cyclin-dependent Kinase 2 Inhibitory Peptide I | 500.micro.g |
| ALX-153-042-C500 | Cyclin-dependent Kinase 2 Inhibitory Peptide II | 500.micro.g |
| ALX-153-043-C100 | Blocking Peptide for PAb tobeta-Chemokine Receptor D6 (human) (Prod. No. ALX-210-839) | 100.micro.g |
| ALX-153-044-C100 | Blocking Peptide for PAb to Caspase-14 (mouse) (Prod. No. ALX-210-842) | 100.micro.g |
| ALX-153-045-C100 | Blocking Peptide for PAb to CCR6 (human) (Prod. No. ALX-210-843) | 100.micro.g |
| ALX-153-046-C100 | Blocking Peptide for PAb to CCR7 (Prod. No. ALX-210-844) | 100.micro.g |
| ALX-153-047-C100 | Blocking Peptide for PAb to CCR8 (mouse) (Prod. No. ALX-210-845) | 100.micro.g |
| ALX-153-048-C100 | Blocking Peptide for PAb to CCR9 (Prod. No. ALX-210-846) | 100.micro.g |
| ALX-153-049-C100 | Blocking Peptide for PAb to CCR9 (human) (Prod. No. ALX-210-847) | 100.micro.g |
| ALX-153-050-C100 | Blocking Peptide for PAb to CCR10 (mouse) (Prod. No. ALX-210-848) | 100.micro.g |
| ALX-153-051-C100 | Blocking Peptide for PAb to CCR10 (human) (Prod. No. ALX-210-849) | 100.micro.g |
| ALX-153-053-C100 | Blocking Peptide for PAb to beta-Chemokine Receptor D6 (mouse) (Prod. No. ALX-210-851) | 100.micro.g |
| ALX-153-054-C050 | Blocking Peptide for PAb to Caveolin-1 (Prod. No. ALX-210-347) | 50.micro.g |
| ALX-153-055-G001 | Carnosine | 1 g |
| ALX-153-056-C050 | Blocking Peptide for PAb to CHIP (human) (Prod. No. ALX-210-883) | 50.micro.g |
| ALX-153-057-C050 | Blocking Peptide for PAb to alpha-COP (Prod. No. ALX-210-884) | 50.micro.g |
| ALX-153-058-C050 | Blocking Peptide for PAb to beta-'-COP (rat) (Prod. No. ALX-210-886) | 50.micro.g |
| ALX-153-060-C050 | Blocking Peptide for PAb to Caveolin-2 (phosphorylated) (pTyr19) (mouse) (Prod. No. ALX-210-888) | 50.micro.g |
| ALX-153-061-C100 | Blocking Peptide for PAb to CCR4 (human) (Prod. No. ALX-210-622) | 100.micro.g |
| ALX-153-062-C050 | Blocking Peptide for PAb to Caspase-3 (active) (Prod. No. 210-807) | 50.micro.g |
| ALX-153-063-C200 | Blocking Peptide for PAb to COX-2 (mouse) (Prod. No. 210-711) | 200.micro.g |
| ALX-154-001-C050 | Blocking Peptide for PAb to Dynamin I [Dyn1] (rat) (Prod. No. ALX-210-207) | 50.micro.g |
| ALX-154-002-C050 | Blocking Peptide for PAb to Dynamin II [Dyn2] (Prod. No. ALX-210-262) | 50.micro.g |
| ALX-154-003-C050 | Blocking Peptide for PAb to Dynamin III [Dyn3] (Prod. No. ALX-210-263) | 50.micro.g |
| ALX-155-001-P001 | Endothelin-1 (human, mouse rat, pig, bovine, dog) | 1 mg* |
| ALX-155-001-PC01 | Endothelin-1 (human, mouse rat, pig, bovine, dog) | 0.1 mg* |
| ALX-155-001-PC05 | Endothelin-1 (human, mouse rat, pig, bovine, dog) | 0.5 mg* |
| ALX-155-002-P001 | Endothelin-2 (human, pig, dog) | 1 mg* |
| ALX-155-002-PC01 | Endothelin-2 (human, pig, dog) | 0.1 mg* |
| ALX-155-002-PC05 | Endothelin-2 (human, pig, dog) | 0.5 mg* |
| ALX-155-003-P001 | Endothelin-3 (human, rat, pig) | 1 mg* |
| ALX-155-003-PC01 | Endothelin-3 (human, rat, pig) | 0.1 mg* |
| ALX-155-003-PC05 | Endothelin-3 (human, rat, pig) | 0.5 mg* |
| ALX-155-004-P001 | ETA-Receptor Antagonist [BQ-123] . sodium salt | 1 mg* |
| ALX-155-004-P005 | ETA-Receptor Antagonist [BQ-123] . sodium salt | 5 mg* |
| ALX-155-005-P001 | ET-Receptor Antagonist [BE-18257A] | 1 mg* |
| ALX-155-005-PC05 | ET-Receptor Antagonist [BE-18257A] | 0.5 mg* |
| ALX-155-006-P001 | ETB-Receptor Agonist [IRL-1620] | 1 mg* |
| ALX-155-006-PC05 | ETB-Receptor Agonist [IRL-1620] | 0.5 mg* |
| ALX-155-007-P001 | ETB-Receptor Antagonist [IRL-1038] | 1 mg* |
| ALX-155-007-PC05 | ETB-Receptor Antagonist [IRL-1038] | 0.5 mg* |
| ALX-155-008-P001 | ET-Receptor Antagonist [PD 142893] | 1 mg* |
| ALX-155-008-PC05 | ET-Receptor Antagonist [PD 142893] | 0.5 mg* |
| ALX-155-009-P001 | ETA-Receptor Antagonist [BE-18257B] | 1 mg* |
| ALX-155-009-PC05 | ETA-Receptor Antagonist [BE-18257B] | 0.5 mg* |
| ALX-155-010-P001 | ETB-Receptor Agonist [4 Ala ET-1] | 1 mg* |
| ALX-155-010-PC05 | ETB-Receptor Agonist [4 Ala ET-1] | 0.5 mg* |
| ALX-155-011-P001 | ETA-Receptor Antagonist [BQ-610] | 1 mg* |
| ALX-155-011-P005 | ETA-Receptor Antagonist [BQ-610] | 5 mg* |
| ALX-155-012-P001 | ETA-Receptor Antagonist [JKC-301] | 1 mg* |
| ALX-155-012-PC05 | ETA-Receptor Antagonist [JKC-301] | 0.5 mg* |
| ALX-155-013-P001 | ETA-Receptor Antagonist [JKC-302] | 1 mg* |
| ALX-155-013-PC05 | ETA-Receptor Antagonist [JKC-302] | 0.5 mg* |
| ALX-155-015-P001 | ETB-Receptor Agonist [BQ-3020] | 1 mg* |
| ALX-155-015-PC05 | ETB-Receptor Agonist [BQ-3020] | 0.5 mg* |
| ALX-155-016-P001 | ET-Receptor Antagonist [PD 145065] | 1 mg* |
| ALX-155-016-PC05 | ET-Receptor Antagonist [PD 145065] | 0.5 mg* |
| ALX-155-017-P001 | ETA-Receptor Antagonist [FR 139317] | 1 mg* |
| ALX-155-017-PC05 | ETA-Receptor Antagonist [FR 139317] | 0.5 mg* |
| ALX-155-018-M001 | ETB-Receptor Antagonist [RES-701-1] | 1 mg |
| ALX-155-018-MC05 | ETB-Receptor Antagonist [RES-701-1] | 0.5 mg |
| ALX-155-019-M001 | ETB-Receptor Antagonist [RES-701-3] | 1 mg |
| ALX-155-019-MC05 | ETB-Receptor Antagonist [RES-701-3] | 0.5 mg |
| ALX-155-020-M001 | ETB-Receptor Antagonist [BQ-788] . sodium salt | 1 mg |
| ALX-155-020-MC05 | ETB-Receptor Antagonist [BQ-788] . sodium salt | 0.5 mg |
| ALX-155-021-M001 | EGF Receptor (human) (651-658) | 1 mg |
| ALX-155-021-M005 | EGF Receptor (human) (651-658) | 5 mg |
| ALX-155-022-M001 | EGF Receptor (human) (651-658) (N-Myristoylated) | 1 mg |
| ALX-155-022-M005 | EGF Receptor (human) (651-658) (N-Myristoylated) | 5 mg |
| ALX-155-023-M001 | EGF Receptor (human) (652-657) | 1 mg |
| ALX-155-023-M005 | EGF Receptor (human) (652-657) | 5 mg |
| ALX-155-024-M001 | ERT Protein Kinase Substrate | 1 mg |
| ALX-155-024-M005 | ERT Protein Kinase Substrate | 5 mg |
| ALX-155-025-C050 | Blocking Peptide for PAb to Estrogen Receptor beta [ERbeta] (Prod. No. ALX-210-132) | 50.micro.g |
| ALX-155-026-M001 | ERT Protein Kinase Substrate Amide | 1 mg |
| ALX-155-026-M005 | ERT Protein Kinase Substrate Amide | 5 mg |
| ALX-155-027-C050 | Blocking Peptide for PAb to Estrogen Receptor beta [ERbeta] (Prod. No. ALX-210-135) | 50.micro.g |
| ALX-155-028-C050 | Blocking Peptide for MAb to Estrogen Receptor alpha [ERalpha] (Prod. No. ALX-803-004) | 50.micro.g |
| ALX-155-029-C050 | Blocking Peptide for PAb to Estrogen Receptor beta [ERbeta] (human) (Prod. No. ALX-210-180) | 50.micro.g |
| ALX-155-030-C050 | Blocking Peptide for PAb to Estrogen Receptor beta [ERbeta] (Prod. No. ALX-210-178) | 50.micro.g |
| ALX-155-031-C050 | Blocking Peptide for PAb to Estrogen Receptor alpha [ERalpha (Prod. No. ALX-210-201) | 50.micro.g |
| ALX-155-032-C050 | Blocking Peptide for PAb to Estrogen Receptor alpha [ERalpha] (Prod. No. ALX-210-202) | 50.micro.g |
| ALX-155-033-C050 | Blocking Peptide for PAb to Early Endosomal Antigen 1 (Prod. No. ALX-210-239) | 50.micro.g |
| ALX-155-034-C050 | Blocking Peptide for PAb to Epithelial Cell Sodium Channel gamma (rat) (Prod. No. ALX-210-299) | 50.micro.g |
| ALX-155-035-C050 | Blocking Peptide for PAb to Epithelial Cell Sodium Channel alpha (rat) (Prod. No. ALX-210-291) | 50.micro.g |
| ALX-155-036-C050 | Blocking Peptide for PAb to Epithelial Cell Sodium Channel beta (rat) (Prod. No. ALX-210-300) | 50.micro.g |
| ALX-156-001-C050 | Blocking Peptide for PAb to Furin Convertase (Prod. No. ALX-210-134) | 50.micro.g |
| ALX-156-002-C050 | Blocking Peptide for PAb to FKBP12 (Prod. No. ALX-210-142) | 50.micro.g |
| ALX-156-003-C050 | Blocking Peptide for PAb to FKBP51 (Prod. No. ALX-210-236) | 50.micro.g |
| ALX-156-004-C050 | Blocking Peptide for PAb to FIAF (Prod. No. ALX-210-360) | 50.micro.g |
| ALX-156-005-C200 | Blocking Peptide for PAb to Fatty Acid Amide Hydrolase [FAAH] (Prod. No. ALX-210-418) | 200.micro.g |
| ALX-157-001-G001 | L-Glutathione (oxidized form) | 1 g |
| ALX-157-001-G005 | L-Glutathione (oxidized form) | 5 g |
| ALX-157-001-M250 | L-Glutathione (oxidized form) | 250 mg |
| ALX-157-002-G001 | L-Glutathione (reduced form) | 1 g |
| ALX-157-002-G005 | L-Glutathione (reduced form) | 5 g |
| ALX-157-002-G025 | L-Glutathione (reduced form) | 25 g |
| ALX-157-003-P001 | Galanin (human) | 1 mg* |
| ALX-157-003-PC05 | Galanin (human) | 0.5 mg* |
| ALX-157-004-P001 | Galanin (pig) | 1 mg* |
| ALX-157-004-PC05 | Galanin (pig) | 0.5 mg* |
| ALX-157-010-M001 | Guanylin (human) | 1 mg |
| ALX-157-010-MC01 | Guanylin (human) | 0.1 mg |
| ALX-157-011-M001 | Guanylin (rat, mouse) | 1 mg |
| ALX-157-011-MC01 | Guanylin (rat, mouse) | 0.1 mg |
| ALX-157-013-M001 | [Ala9,10, Lys11,12]-Glycogen Synthase (1-12) | 1 mg |
| ALX-157-013-M005 | [Ala9,10, Lys11,12]-Glycogen Synthase (1-12) | 5 mg |
| ALX-157-014-M001 | H-Gly-Arg-Gly-Leu-Ser-Leu-Ser-Arg-OH | 1 mg |
| ALX-157-014-M005 | H-Gly-Arg-Gly-Leu-Ser-Leu-Ser-Arg-OH | 5 mg |
| ALX-157-015-C050 | Blocking Peptide for PAb to Glucocorticoid Receptor [GR] (Prod. No. ALX-210-131) | 50.micro.g |
| ALX-157-016-C050 | Blocking Peptide for PAb to Glucocorticoid Receptor [GR] (Prod. No. ALX-210-153) | 50.micro.g |
| ALX-157-018-C050 | Blocking Peptide for PAb to Green Fluorescent Protein (Prod. No. ALX-210-199) | 50.micro.g |
| ALX-157-019-C050 | Blocking Peptide for PAb to Glucocorticoid Receptor Interacting Protein-1 (Prod. No. ALX-210-286) | 50.micro.g |
| ALX-157-020-MC01 | Galanin Like Peptide [GALP] (1-60) (pig) | 0.1 mg |
| ALX-157-021-MC05 | Ghrelin (human) | 0.5 mg |
| ALX-157-021-M001 | Ghrelin (human) | 1 mg |
| ALX-157-022-MC05 | Ghrelin (rat) | 0.5 mg |
| ALX-157-022-M001 | Ghrelin (rat) | 1 mg |
| ALX-157-023-C200 | Blocking Peptide for PAb to Guanylyl Cyclase beta1, Soluble (ALX-210-867) | 200.micro.g |
| ALX-157-024-C200 | Blocking Peptide for PAb to Guanylyl Cyclase (alpha Subunit), Soluble (Prod. No. ALX-210-878) | 200.micro.g |
| ALX-158-001-M001 | Histone H1-7 Substrate | 1 mg |
| ALX-158-001-M005 | Histone H1-7 Substrate | 5 mg |
| ALX-158-002-M001 | [Ala32]-Histone H2B (29-35) | 1 mg |
| ALX-158-002-M005 | [Ala32]-Histone H2B (29-35) | 5 mg |
| ALX-158-003-M001 | Histone H2B (29-35) | 1 mg |
| ALX-158-003-M005 | Histone H2B (29-35) | 5 mg |
| ALX-158-004-M001 | [Ala34]-Histone H2B (29-35) | 1 mg |
| ALX-158-004-M005 | [Ala34]-Histone H2B (29-35) | 5 mg |
| ALX-158-005-M001 | Hymenistatin | 1 mg |
| ALX-158-005-MC05 | Hymenistatin | 0.5 mg |
| ALX-158-006-C050 | Blocking Peptide for PAb to Histone Deacetylase 1 (Prod. No. ALX-210-256) | 50.micro.g |
| ALX-158-007-C050 | Blocking Peptide for PAb to Histone Deacetylase 2 (Prod. No. ALX-210-257) | 50.micro.g |
| ALX-158-008-C050 | Blocking Peptide for PAb to Histone Deacetylase 3 (Prod. No. ALX-210-258) | 50.micro.g |
| ALX-158-009-C050 | Blocking Peptide for PAb to Histone Deacetylase 4 (human) (CT) (Prod. No. ALX-210-338) | 50.micro.g |
| ALX-158-011-MC05 | Humanin (human) | 0.5 mg |
| ALX-158-011-M001 | Humanin (human) | 1 mg |
| ALX-159-001-M001 | IL-2 Receptor Fragment (human) | 1 mg |
| ALX-159-003-C050 | Blocking Peptide for PAb to Inositol-1,4,5-trisphosphate Receptor (Type-1) (Prod. No. ALX-210-115 & ALX-210-169) | 50.micro.g |
| ALX-159-004-C050 | Blocking Peptide for PAb to Inositol-1,4,5-trisphosphate Receptor (Type-II) (rat) (Prod. No. ALX-210-224) | 50.micro.g |
| ALX-159-005-C050 | Blocking Peptide for PAb to Inositol Hexakisphosphate [IP6] Kinase (rat) (Prod. No. ALX-210-289) | 50.micro.g |
| ALX-159-006-C100 | Blocking Peptide for PAb to IL-21 (human) (C-terminal) (Prod. No. ALX-210-624) | 100.micro.g |
| ALX-159-007-C100 | Blocking Peptide for PAb to IL-21 (human) (N-terminal) (Prod. No. ALX-210-625) | 100.micro.g |
| ALX-159-008-C100 | Blocking Peptide for PAb to IL-21 (mouse) (C-terminal) (Prod. No. ALX-210-626) | 100.micro.g |
| ALX-159-009-C100 | Blocking Peptide for PAb to IL-21 (mouse) (N-terminal) (Prod. No. ALX-210-627) | 100.micro.g |
| ALX-159-010-C100 | Blocking Peptide for PAb to IL-22 (C-terminal) (Prod. No. ALX-210-628) | 100.micro.g |
| ALX-159-011-C100 | Blocking Peptide for PAb to IL-22 (human) (N-terminal) (Prod. No. ALX-210-629) | 100.micro.g |
| ALX-159-012-C100 | Blocking Peptide for PAb to IL-22 (mouse) (N-terminal) (Prod. No. ALX-210-630) | 100.micro.g |
| ALX-159-013-C100 | Blocking Peptide for PAb to to IL-21 Receptor (human) (Prod. No. ALX-210-631) | 100.micro.g |
| ALX-159-014-C100 | Blocking Peptide for PAb to IL-21 Receptor (mouse) (Prod. No. ALX-210-632) | 100.micro.g |
| ALX-159-015-C100 | Blocking Peptide for PAb to to IL-22 Receptor-alpha 2 (human) (Prod. No. ALX-210-633) | 100.micro.g |
| ALX-159-016-C100 | Blocking Peptide for PAb to IL-22 Receptor (human) (Prod. No. ALX-210-634) | 100.micro.g |
| ALX-159-017-C100 | Blocking Peptide for PAb to IL-21 Receptor-alpha (mouse) (Prod. No. ALX-210-635) | 100.micro.g |
| ALX-159-600-R100 | JNK Inhibitor 1 (L-stereoisomer) | 100.micro.l |
| ALX-159-600-R200 | JNK Inhibitor 1 (L-stereoisomer) | 200.micro.l |
| ALX-160-002-M001 | Kemptamide | 1 mg |
| ALX-160-002-M005 | Kemptamide | 5 mg |
| ALX-160-006-M001 | Kemptide | 1 mg |
| ALX-160-006-M005 | Kemptide | 5 mg |
